Data are presented as median [interquartile range]. Bolded values indicate P < 0.05. ALP, alkaline phosphatase; SGPT, serum glutamic pyruvic transaminase; ALT, alanine aminotransferase; SGOT, serum glutamic-oxaloacetic transaminase; GGT, gamma-glutamyl transferase; AST, aspartate aminotransferase; CPK, creatine phosphokinase; BUN, blood urea nitrogen.
| Placebo | S-HDL | P | |
| ALP (U/liter) | 127 [87–175] | 85 [70–132] | 0.15 |
| SGPT (ALT) (U/liter) | 45 [39–67] | 51 [38–65] | 0.94 |
| SGOT (AST) (U/liter) | 69 [43–222] | 67 [53–160] | 0.80 |
| GGT (U/liter) | 40 [34–78] | 41 [39–56] | 0.67 |
| CPK (U/liter) | 740 [406–1817] | 796 [431–1024] | 0.94 |
| Total bilirubin (mg/dl) | 0.2 [0.1–0.2] | 0.2 [0.2–0.3] | 0.28 |
| Direct bilirubin (mg/dl) | 0.0 [0.0–0.1] | 0.0 [0.0–0.1] | >0.99 |
| Indirect bilirubin (mg/dl) | 0.1 [0.1–0.2] | 0.2 [0.1–0.3] | 0.37 |
| Total protein (g/dl) | 6.6 [5.9–6.7] | 6.8 [6.5–7.1] | 0.21 |
| Albumin (g/dl) | 3.5 [3.4–4.0] | 4.0 [3.7–4.5] | 0.29 |
| Globulin (g/dl) | 2.6 [2.5–3.1] | 2.8 [2.5–2.9] | 0.81 |
| Albumin/ globulin ratio | 1.4 [1.2–1.6] | 1.4 [1.3–1.8] | 0.75 |
| BUN (mg/dl) | 12 [10–14] | 10 [8.5–17] | 0.79 |
| Creatinine (mg/dl) | 0.9 [0.8–1.2] | 1.0 [0.9–1.2] | 0.69 |
| BUN/creatinine ratio | 13 [9.1–17] | 11 [9.0–15] | 0.94 |
| Glucose (mg/dl) | 76 [71–80] | 67 [34–69] | 0.03 |
| Cholesterol (mg/dl) | 573 [450–628] | 507 [426–747] | 0.80 |
| Triglycerides (mg/dl) | 62 [26–72] | 72 [48–186] | 0.31 |
| Sodium (mM) | 140 [140–141] | 139 [136–141] | 0.20 |
| Potassium (mM) | 4.4 [4.3–5.1] | 4.6 [4.1–7.5] | 0.44 |
| Na/K ratio | 32 [28–33] | 30 [21–35] | 0.44 |
| Magnesium (mg/dl) | 2.0 [1.9–2.4] | 2.1 [1.9–2.8] | 0.81 |
| Calcium (mg/dl) | 10 [9.4–11] | 10 [9.9–10.2] | 0.88 |
| Phosphorus (mg/dl) | 7.4 [7.2–7.9] | 6.9 [6.4–8.6] | 0.53 |
| Bicarbonate (mM) | 22 [19–24] | 19 [17–24] | 0.49 |
| Chloride (mM) | 99 [98–101] | 102 [97–105] | 0.49 |